Pay in 4 interest-free payments of $5.47 Learn more
Ships within 48 hours Β· Estimated delivery Aug 23 - Aug 28
Liraglutide vs Semaglutide vs GLP-1 for Weight Loss Liraglutide and Semaglutide GLP-1, both GLP-1 receptor agonists, play key roles in promoting weight loss by increasing satiety and reducing appetite, though Semaglutide GLP-1 often shows superior efficacy due to its longer duration in the body and stronger receptor affinity
Oral semaglutide for weight loss is primarily prescribed as part of a comprehensive weight management strategy that involves nutritional modifications and increased physical activity
Kahles F, Liberman A, Halim C, Rau M, Mollmann J, Mertens RW, Ruckbeil M, Diepolder I, Walla B, Diebold S, et al
This information helps inform decisions about continued use and identifies any concerning trends early
In the 2026 ADA Scientific Sessions, results from the Phase-3 TRANSCEND-T2D-1 study involving retatrutide, a triple agonist of GLP-1, GIP, and glucagon receptors, showed up to a 2% decrease in A1C and a 16.8% decrease in body weight over 40 weeks in patients with type 2 diabetes
